Tomizawa D, Miyamura T, Imamura T, et al. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial. Blood. 2020;136(16):1813-1823.

In the last paragraph of the left column on page 1821, in the passage “infants younger than age 2 months and those age 2 to 4 months received two-thirds and three-quarters of the calculated doses in MLL-10, respectively,” “2 to 4 months” should read “2 to 3 months.” In footnote “a” in supplemental Tables 2 and 3, “2 to 4 months of age” should read “2 to 3 months of age.” The errors have been corrected in the published article and supplemental file.